	eastman kodak ek to sell holdings eastman kodak co said it plans to sell its pct holding in icn pharmaceuticals icn and part of its nine pct holdings in viratek vira it said the purpose of the investments had been to lay the groundwork for the creation of its nucleic acid research institute since that has been achieved there is no longer any reason to maintain the equity positions kodak said kodak holds sahres of icn currently trading at about and of viratek trading at reuter 
